Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Influence of ritonavir on olanzapine pharmacokinetics in healthy volunteers
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Influence of ritonavir on olanzapine pharmacokinetics in healthy volunteers'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Area under the Concentration-time Curve
9%
Atypical Antipsychotics
9%
Blood Samples
18%
Cytochrome P450 1A2 (CYP1A2)
9%
Glucuronosyltransferase
9%
Healthy Volunteers
100%
HIV Infection
9%
HIV Protease Inhibitors
9%
Noncompartmental
9%
Olanzapine
100%
Oral Clearance
9%
Parameter Values
9%
Peak Concentration
9%
Pharmacokinetic Parameters
9%
Pharmacokinetics
100%
Plasma Samples
9%
Psychotic Illness
9%
Ritonavir
100%
Student's T-test
9%
Systemic Exposure
9%
Therapeutic Effect
9%
Twice Daily
27%
Pharmacology, Toxicology and Pharmaceutical Science
Atypical Antipsychotics
9%
CYP1A2
9%
Disease
9%
Glucuronosyltransferase
9%
High Performance Liquid Chromatography
9%
Human Immunodeficiency Virus Infection
9%
Human Immunodeficiency Virus Proteinase Inhibitor
9%
Normal Human
100%
Olanzapine
100%
Pharmacokinetic Parameter
9%
Pharmacokinetics
100%
Ritonavir
100%
Therapeutic Effect
9%